SCHEMBL4631702

SCHEMBL4631702

COc1cc(F)c(F)cc1NC1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.41
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
HTR2B P41595 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PDGFRB P09619 5/20 0.38
PDGFRA P16234 5/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 2/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37
EGFR P00533 1/20 0.37
INSR P06213 1/20 0.37
LCK P06239 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30003208 0.80 L3MBTL1 (0.48) NPSR1L3MBTL1ALDH1A1LMNAPOLB
SCHEMBL17048125 0.77 KMT2A (0.47) ROCK2LMNAPOLBHTTKMT2A
SCHEMBL20353615 0.76 ROCK2 (0.42) ROCK2KDM4EMAPTGAAHPGD
SCHEMBL28413236 0.75 APP (0.42) HTR2AHTR2CHTR2BALDH1A1LMNA
SCHEMBL4519070 0.74 ROCK2 (0.52) ROCK2NPSR1ALDH1A1KDM4EMAPT
SCHEMBL26191686 0.73 ALDH1A1 (0.43) ROCK2HTR2AHTR2CHTR2BALDH1A1
SCHEMBL10175794 0.72 ROCK2 (0.46) ROCK2KDM4EMAPTGAAHPGD
SCHEMBL29525834 0.72 ROCK2 (0.46) ROCK2KDM4EMAPTGAAHPGD
SCHEMBL13450008 0.72 HRH2 (0.49) ROCK2ALDH1A1POLBHTTGAA
SCHEMBL4630869 0.72 MEN1 (0.62) HTR2AHTR2CHTR2BL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470103-B1 AMIDOACETONITRILE DERIVATIVES NOVARTIS AG (CH) 2008-05-14 EP disclosed
US-7153814-B2 Amidoacetonitrile derivatives NOVARTIS ANIMAL HEALTH US, INC. (US) 2006-12-26 US disclosed
US-20050059736-A1 Amidoacetonitrile derivatives NOVARTIS ANIMAL HEALTH US, INC. 2005-03-17 US disclosed
EP-1470103-A1 AMIDOACETONITRILE DERIVATIVES Novartis AG (CH) 2004-10-27 EP disclosed
WO-2003059868-A1 AMIDOACETONITRILE DERIVATIVES NOVARTIS AG (CH) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059736-A1 Amidoacetonitrile derivatives ARG1, NAT1, NMBR ROCK2 2761/4885HTR2A 3415/4885HTR2C 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.